Viruses continue to evolve and emerge as virulent pathogens causing significant loss of human lives and economic activities. This is acutely exemplified by COVID-19 causing SARS-CoV-2 and its variants. One of the strategies to deal with such emergent pathogens is their early detection requiring the development of massively deployable technologies. In line with this, the team will propose to engineer a versatile biosensor platform (BioNAD) for highly sensitive and specific, rapid, and cost-effective virus detection in patient or environmental samples.